Document Detail

Changes in skin barrier during treatment with systemic alitretinoin: focus on skin susceptibility and stratum corneum ceramides.
MedLine Citation:
PMID:  20535487     Owner:  NLM     Status:  In-Process    
Alitretinoin is a new drug for systemic treatment of chronic hand eczema. Previous functional tests of skin topically treated with retinoids have indicated impaired skin barrier function, but no data are available on barrier parameters after systemic alitretinoin treatment. To investigate the effect of systemic alitretinoin on skin barrier function and response to irritants, a secondary objective was to determine if changes occur in the lipid profile of stratum corneum after treatment with systemic alitretinoin. We conducted an open clinical intervention study on eight people ascribed to systemic alitretinoin treatment. The criteria for being ascribed to alitretinoin were chronic hand eczema and insufficient therapeutic response to potent topical corticosteroids. Before initiation and after 2 months of systemic treatment with 30 mg alitretinoin, a challenge with sodium lauryl sulphate (SLS) was performed on the volar forearm and evaluated by trans-epidermal water loss (TEWL), erythema, and a cyanoacrylate skin sample was obtained for lipid analysis. We found no significant changes in response to SLS irritation as evaluated by TEWL and erythema, after treatment with alitretinoin for 2 months. No significant changes in stratum corneum lipids were found after 2 months of treatment. In conclusion, systemic alitretinoin does not influence skin susceptibility to irritants or the ceramide profile of stratum corneum.
Jakob Mutanu Jungersted; Julie K Høgh; Lars I Hellgren; Gregor B E Jemec; Tove Agner
Related Documents :
21872317 - Effects of hoechst 33342 staining and ultraviolet irradiation on the developmental comp...
19888947 - Long-term results after reconstruction of full thickness scalp defects with a dermal re...
6084937 - Dapsone in the treatment of kaposi's sarcoma.
7547397 - Dapsone versus topical immunotherapy in alopecia areata.
3800707 - Successful declotting of arteriovenous grafts with local infusion of urokinase in hemod...
6317737 - Lessons from the u.s. multicenter trial of ranitidine treatment for duodenal ulcer.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-06-10
Journal Detail:
Title:  Archives of dermatological research     Volume:  302     ISSN:  1432-069X     ISO Abbreviation:  Arch. Dermatol. Res.     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-10-04     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8000462     Medline TA:  Arch Dermatol Res     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  653-6     Citation Subset:  IM    
Department of Dermatology, University of Copenhagen, Roskilde Hospital, Roskilde, Denmark.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Capillary cerebral amyloid angiopathy identifies a distinct APOE epsilon4-associated subtype of spor...
Next Document:  Patient satisfaction and treatment outcome of fungus ball rhinosinusitis treated by functional endos...